Cardiovascular Safety of Lubeluzole (Prosynap®) in Patients with Ischemic Stroke

Publisher： Karger

E-ISSN： 1421-9786|8|5|247-254

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.8, Iss.5, 1998-08, pp. : 247-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insomnia in Ischemic Stroke Patients

By  

Cerebrovascular Diseases, Vol. 14, Iss. 2, 2002-08 ,pp. : 90-97

Karger

Access to resources Recommend Favorite

Rationale and Design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study

By  

Cerebrovascular Diseases, Vol. 27, Iss. 3, 2009-05 ,pp. : 28-32

Karger

Access to resources Recommend Favorite

The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study: Baseline Characteristics of the Population

By  

Cerebrovascular Diseases, Vol. 27, Iss. 6, 2009-04 ,pp. : 608-613

Karger

Access to resources Recommend Favorite

Hydroxyethyl Starch for Hypervolemic Hemodilution in Patients with Acute Ischemic Stroke: A Randomized, Placebo-Controlled Phase II Safety Study

By  

Cerebrovascular Diseases, Vol. 14, Iss. 1, 2002-06 ,pp. : 33-41

Karger

Access to resources Recommend Favorite

Safety and Therapeutical Benefit of Hemicraniectomy Combined with Mild Hypothermia in Comparison with Hemicraniectomy Alone in Patients with Malignant Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 21, Iss. 1-2, 2006-01 ,pp. : 79-85

Karger

Access to resources Recommend Favorite